Tokyo, Japan

Hiroshi Mizuno

This inventor holds 15 USPTO granted patents and 4 published patent applications and 9 EPO patents, primarily in Biotechnology Innovations. Top assignees: Google Inc., Sankyo Company, Limited, Nec Soft, Ltd.. Active years: 1994-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Mizuno. Retrieved from https://idiyas.com/inventor/hiroshi-mizuno-31sqvdmu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 86.7

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Ibaraki, JP (2008 - 2011)
  • Koto-ku, JP (2012)
  • Tokyo, JP (1994 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Fluorescent Protein
Nucleic Acid Molecule
Amino Acid Derivatives
Nitroxyalkylamide Derivatives
Oxazolidinone Compounds
Thiazolidone Compounds
Pressure Sensor
Transcoding Resources
15 patents (USPTO):Explore Patents

Title: Hiroshi Mizuno: Innovator in Nucleic Acid and Fluorescent Protein Technologies

Introduction

Hiroshi Mizuno, an accomplished inventor hailing from Ibaraki, Japan, has made significant contributions to the fields of biotechnology and molecular sciences. With a total of three patents to his name, Mizuno's work focuses on groundbreaking innovations, particularly in the development of nucleic acid molecules and fluorescent proteins.

Latest Patents

Mizuno's latest patents include:

1. **Nucleic Acid Molecule Capable of Binding to Rabbit-Derived IgG Antibody**: This invention introduces a nucleic acid molecule that exhibits the ability to bind effectively to a rabbit anti-mouse IgG antibody. The innovative aspect of this nucleic acid is its ease of preparation compared to traditional antibodies while maintaining a binding capability equal to or superior to that of conventional antibodies. The sequences delineated in SEQ ID NOS: 1 to 5 represent key components of this invention, with a binding constant (K) of 1.18×10 (M) or less related to the binding with the rabbit IgG antibody.

2. **Fluorescent Protein and Gene Encoding the Same**: In this patent, Mizuno presents a novel fluorescent protein, characterized by a fluorescence maximum wavelength exceeding 510 nm, exhibiting yellow or yellowish-green fluorescence. This protein can be expressed in heterogeneous cells, marking a significant advancement in biological tagging and imaging technologies. The protein’s amino acid sequence outlined in SEQ ID NO: 1 is derived from the copepod species.

Career Highlights

Mizuno has had a diverse career, with notable tenure at companies such as NEC Soft, Ltd. and the National Institute of Agrobiochemical Science. His work at these institutions has positioned him as a key innovator, helping to bridge the gap between academic research and practical applications in biotechnology.

Collaborations

Collaboration has been a vital aspect of Mizuno's accomplishments. He has worked closely with esteemed colleagues like Frederick I. Tsuji and Kenji Takase, fostering an environment of mutual innovation and shared expertise that has enhanced the development of his patented technologies.

Conclusion

Hiroshi Mizuno's contributions to the fields of nucleic acids and fluorescent proteins exemplify the importance of innovation in scientific research. His patents not only advance the understanding and application of these technologies but also serve as a testament to his skills and dedication as an inventor in the rapidly evolving landscape of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…